MUSC Health


Cholesterol-lowering drug tested for effect on prostate cancer tumors

August 31, 2022

“We have a much larger minority population, and so the ability for us to identify how this type of intervention may impact a variety of minority or underserved populations is interesting,” said Stephen Savage, MD, vice chairman of the Department of Urology.

New Hollings study reveals barriers, presents solutions to improve prostate cancer screening among Black men

January 25, 2022

“This study is a great example of research questions coming directly out of clinical practice. It’s so important to listen to patients, understand their experiences and use research findings to guide clinical practice about how best to talk with and advise patients," says Katherine Sterba, PhD.

Hollings' SC AMEN Program for prostate cancer screening launches with enthusiastic support

January 24, 2022

“I think this is a tremendous opportunity for the Black community and for Black men. I hope my story can encourage other men to get prostate cancer screenings and possibly save a life. Every life is important," says Larry J. Ferguson, DMD.